Curis, Inc. (CRIS) - NASDAQ

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Company Description
Curis, Inc. is a biotechnology company, which is to develop and commercialize innovative drug candidates for the treatment of human cancers. Its pipeline includes two clinical stage drug candidates: CUDC-907, a dual HDAC and PI3K inhibitor, and CUDC-427, a small molecule IAP antagonist. The... More
Sector: Healthcare
Industry: Biotechnology
Country: United States